Skip to content

To study the effectiveness of Vamana karma & Vamana karma followed by Nasya karmain Artavakshaya(PCOS)

A COMPARATIVE CLINICAL STUDY TO EVALUATE THE EFFICACY OF VAMANA KARMA AND VAMANA KARMA FOLLOWED BY NASYA KARMA IN THE MANAGEMENT OF ARTAVAKSHAYA W.S.R. TO PCOS

Status
Recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/05/053271
Enrollment
30
Registered
2023-05-30
Start date
Unknown
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E282- Polycystic ovarian syndrome

Interventions

None listed

Sponsors

Parul Ayurved Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: â®? Both married / unmarried females in age group of 18-40 years â®? Patients having symptoms of PCOS (any two given by ASRM & ESHRE) â®? Oligomenorrhea and /or Anovulation â®? Polycystic Ovaries. â®? Patients indicated for Vamana karma â®? Patients indicated for Nasya karma

Exclusion criteria

Exclusion criteria: 1. Patients contraindicated for Vamana karma 2. Patients contraindicated for Nasya karma 3. Cervical tumour, polyp, carcinoma of cervix. 4. Uterine fibroid, 5. Congenital anomalies of female genital tract 6. Chronic illness

Design outcomes

Primary

MeasureTime frame
Helps in menstrual irregularities, reduction in weight & regulating H-P-O axisTimepoint: Group A- 18 days of Vamana karma & after that follow up on next menses Group B- 18 days of Vamana karma and 8 days for Nasya karma Next month after cessation of menses from 5th day onwards Nasya for 8 days similarly for two months and followed up on 4th month

Secondary

MeasureTime frame
Improvement in quality of life & reduced the risk of lifestyle disordersTimepoint: 18 months

Countries

India

Contacts

Public ContactDr Mahesh M Parappagoudra

Parul Institute of Ayurved

mahesh.parappagoudra26812@paruluniversity.ac.in9880988563

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026